31515673_web1_2023010900010-63bba005821cf083b833af5ajpeg

  • Jan. 9, 2023 11:30 a.m.

This image provided by Novo Nordisk shows packaging for the company’s Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A studypublished in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP)

Pop-up banner image